AstraZeneca's Imfinzi fails in late-stage trial to treat lung cancer cases 0 25.06.2024 12:34 Business Standard Imfinzi is a human monoclonal antibody, which works to block a tumour's ability to evade and dampen the immune system, while also boosting the body's anti-cancer immune response Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа
